BioCentury
ARTICLE | Company News

Medisyn, Mount Sinai School of Medicine deal

September 17, 2007 7:00 AM UTC

Medisyn will apply its Forward Engineering in silico discovery platform to information derived from the structure of the school's first-generation Alzheimer's disease (AD) compounds that inhibit gener...